Cambrian BioPharma Inc funding

Cambrian BioPharma Inc, a biotechnology company based in New York, NY, filed a Form D with the SEC on July 15, 2026 and reported $124M raised of a $130M offering.

Amount raised$124M

Offering size$130M

Filed with the SECJuly 15, 2026

First saleJune 30, 2026

IndustryBiotechnology

SecuritiesEquity

LocationNew York, NY

FoundedMore than 5 years ago

Entity typeCorporation

Investors so far80

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Jul 15

Other health care rounds in New York

Precision Neuroscience Corp$250M · Sep 28Other Health Care Click Therapeutics, Inc.$50M · Oct 1Other Health Care Amani Therapeutics, Inc.$35M · Oct 1Other Health Care Atmos Clinic, Inc.$6M · Oct 8Other Health Care CAD Therapeutics, Inc.$4M · Oct 2Biotechnology PreciseDx, Inc.$3.7M · Oct 7Other Health Care Hypercell Technologies Inc.$3M · Oct 14Biotechnology AmorSui Inc.$2.7M · Sep 23Other Health Care